On the other hand, pFN (lacking an EDA segment) level in the plasma samples of patients with high and low risk of CAD did not differ from that in the normal group (Fig. 1a), and its diagnostic usefulness has been reported to be controversial, being probably due to different exclusion criteria for patients and differential timing of FN measurements in relationships to disease [16]. This evidence concerns the gene FN1 and coronary artery disorder.